A Phase 1/2 vaccine safety and immunogenicity study of RiVax
Phase of Trial: Phase I/II
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Ricin vaccine (Primary)
- Indications Ricin poisoning
- Focus Adverse reactions; Pharmacodynamics
- 26 Jul 2018 According to a Soligenix media release, a Phase II study has been planned to initiate in the second half of 2018 is contingent upon exercise of the final option by the US government under NIAID contract #HHSN272201400039C and/or through other funding sources.
- 31 Jan 2018 New trial record
- 25 Jan 2018 According to a Soligenix media release, the company expects to initiate this trial in 2018.